FDA Rejects Ocugen’s Application of Covaxin
The US Food and Drug Administration (FDA) has rejected the proposal for emergency use authorization (EUA) of Bharat Biotech’s Covaxin. Ocugen, which has done a...
Download Unicorn Signals App
Powered By EquityPandit
